2,2'-dipyridyl has been researched along with Cancer of Ovary in 7 studies
2,2'-Dipyridyl: A reagent used for the determination of iron.
2,2'-bipyridine : A bipyridine in which the two pyridine moieties are linked by a bond between positions C-2 and C-2'.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Georgakopoulou, C | 1 |
| Thomos, D | 1 |
| Tsolis, T | 1 |
| Ypsilantis, K | 1 |
| Plakatouras, JC | 1 |
| Kordias, D | 1 |
| Magklara, A | 1 |
| Kouderis, C | 1 |
| Kalampounias, AG | 1 |
| Garoufis, A | 1 |
| Gamberi, T | 2 |
| Massai, L | 2 |
| Magherini, F | 2 |
| Landini, I | 2 |
| Fiaschi, T | 2 |
| Scaletti, F | 1 |
| Gabbiani, C | 2 |
| Bianchi, L | 2 |
| Bini, L | 2 |
| Nobili, S | 2 |
| Perrone, G | 1 |
| Mini, E | 2 |
| Messori, L | 2 |
| Modesti, A | 2 |
| Valocchia, E | 1 |
| Shahsavar, F | 1 |
| Bozorgmehr, M | 1 |
| Mirzadegan, E | 1 |
| Abedi, A | 1 |
| Lighvan, ZM | 1 |
| Mohammadi, F | 1 |
| Safari, N | 1 |
| Amani, V | 1 |
| Zarnani, AH | 1 |
| Bugarcic, T | 1 |
| Habtemariam, A | 1 |
| Stepankova, J | 1 |
| Heringova, P | 1 |
| Kasparkova, J | 1 |
| Deeth, RJ | 1 |
| Johnstone, RD | 1 |
| Prescimone, A | 1 |
| Parkin, A | 1 |
| Parsons, S | 1 |
| Brabec, V | 1 |
| Sadler, PJ | 1 |
| Marverti, G | 2 |
| Ligabue, A | 2 |
| Montanari, M | 1 |
| Guerrieri, D | 1 |
| Cusumano, M | 2 |
| Di Pietro, ML | 2 |
| Troiano, L | 1 |
| Di Vono, E | 1 |
| Iotti, S | 1 |
| Farruggia, G | 1 |
| Wolf, F | 1 |
| Monti, MG | 1 |
| Frassineti, C | 2 |
| Vainiglia, PA | 1 |
| Ferrari, A | 1 |
| Bergomi, M | 1 |
| Moruzzi, MS | 1 |
7 other studies available for 2,2'-dipyridyl and Cancer of Ovary
| Article | Year |
|---|---|
Synthesis, characterization, interactions with the DNA duplex dodecamer d(5'-CGCGAATTCGCG-3')
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Cell Line, Tumor; DNA; Ethane; Female; Humans; Ovarian Neopla | 2022 |
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c).
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Female; Glycolysis; Hum | 2014 |
Proteomic analysis of the cytotoxic effects induced by the organogold(III) complex Aubipyc in cisplatin-resistant A2780 ovarian cancer cells: further evidence for the glycolytic pathway implication.
Topics: 2,2'-Dipyridyl; Antineoplastic Agents; Blotting, Western; Cell Line, Tumor; Cisplatin; Drug Resistan | 2015 |
A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
Topics: 2,2'-Dipyridyl; Amniotic Fluid; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cisplatin; Dimet | 2016 |
The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Topics: 2,2'-Dipyridyl; Cations; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Female; Humans; Hy | 2008 |
Characterization of the cell growth inhibitory effects of a novel DNA-intercalating bipyridyl-thiourea-Pt(II) complex in cisplatin-sensitive and -resistant human ovarian cancer cells.
Topics: 2,2'-Dipyridyl; Cell Cycle; Cell Fusion; Cell Line, Tumor; Cell Membrane Permeability; Cell Prolifer | 2011 |
Studies on the anti-proliferative effects of novel DNA-intercalating bipyridyl-thiourea-Pt(II) complexes against cisplatin-sensitive and -resistant human ovarian cancer cells.
Topics: 2,2'-Dipyridyl; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA; Drug Resistance, Neoplasm; Dru | 2008 |